• Sections
  • Newsletters
  • Podcasts
  • Support TPM
  • Shop Merch
  • Site Info
  • About
  • Sections
  • Editors' Blog
  • News
  • Live Blog
  • Cafe
  • Muckraker
  • Morning Memo
  • Where Things Stand
  • The Weekender
  • The Franchise
  • Features
  • Support TPM
  • Memberships
  • The TPM Journalism Fund
  • Site Info
  • FAQ
  • Contact
  • Advertise
  • Terms
  • Privacy
  • Site Status
  • About
  • About TPM
  • Mission
  • Masthead
  • Financials
  • Careers
  • Pitch Us
Follow TPM
© 2026 TPM MEDIA LLC. ALL RIGHTS RESERVED.
Talking Points Memo Logo
Send Tips TPM 25th Anniversary Badge
Donald Trump
Trump Attacks Whitmer After Feds Foil Plot To Kidnap Her, Complains She Hasn’t Thanked Him
By Cristina Cabrera
10.09.20 | 8:59 am
Trump Says He Plans On Holding Rally On Saturday, Won’t Say If He’s Tested Negative
By Cristina Cabrera
10.09.20 | 7:50 am
Trump Runs Away From Second Debate: Reactions And Fallout
By Summer Concepcion
10.08.20 | 7:04 pm
TARRYTOWN, NEW YORK, UNITED STATES - 2020/10/02: View of Corporate and Research and Development Headquarters of Regeneron Pharmaceuticals, Inc. on Old Saw Mill River Road. As President Donald Trump contracted COVID-19 he has been administered a dose of experimental Regeneron treatment, according to a memorandum from the President's physician. According to company press release antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19. REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19. (Photo by Lev Radin/Pacific Press/LightRocket via Getty Images) TARRYTOWN, NEW YORK, UNITED STATES - 2020/10/02: View of Corporate and Research and Development Headquarters of Regeneron Pharmaceuticals, Inc. on Old Saw Mill River Road. As President Donald Trump contracted COVID-19 he has been administered a dose of experimental Regeneron treatment, according to a memorandum from the President's physician. According to company press release antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19. REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19. (Photo by Lev Radin/Pacific Press/LightRocket via Getty Images)
President Plays Pitchman For Another Experimental COVID ‘Cure’ Prime Badge
This Week in the Swamp: A weekly dive into the muck of the Trump administration.
By Matt Shuham
10.08.20 | 6:07 pm
Where Things Stand: Different Standards Are McConnell’s Favorite Cop-Out Prime Badge
This is your TPM afternoon briefing.
By Nicole LaFond
10.08.20 | 1:50 pm

The Senate majority leader’s hazy statements distancing himself from the administration’s missteps are a staple of his leadership in the Trump era.

Read More

Donald ‘Law And Order’ Trump Keeps Blaming Cops And Soldiers For Giving Him COVID
By Kate Riga
10.08.20 | 12:57 pm
Report: Trump Plans To Hit The Campaign Trail Again As Soon As Monday
By Cristina Cabrera
10.08.20 | 9:23 am
Trump Bails On Next Debate After Commission Announces Virtual Format
By Cristina Cabrera
10.08.20 | 7:49 am
Instead Of Promising He’d Step Down If He Loses, Pence Spouts Conspiracy Theories
By Kate Riga
10.07.20 | 11:37 pm
Trump Admin Suffers Another Setback In Census Gambit, But Still Has Options
By Tierney Sneed
10.07.20 | 5:28 pm
Next →
Talking Points Memo
© 2026 TPM MEDIA LLC.
Masthead Contact Privacy Policy
  • About
  • Memberships
  • Careers
  • Advertise
  • Site Status
  • FAQ
  • Newsletters
  • Pitch Us
  • Terms of Use
  • CCPA Notice